The global methicillin-resistant staphylococcus aureus (MRSA) drug market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Amongst the variety of microbial flora present in human body, staphylococcus aureus, a gram-positive bacterium, is the most commonly bacteria found on the surface of skin as well as nasal passages of humans. The market growth is majorly attributable to the growing prevalence of staphylococcus aureus all over the globe. According to the US Department of Health (USDoH), 20% of the global population is always colonized with staphylococcus aureus. Being a facultative anaerobe, it can cause respiratory diseases, skin illness, and food poisoning.
To Request a Sample of our Report on Methicillin-Resistant Staphylococcus Aureus (MRSA) Drug Market: https://www.omrglobal.com/request-sample/methicillin-resistant-staphylococcus-aureus-mrsa-drug-market
According to the Health Research Funding Organization, nearly 19,000 mortalities are registered globally due to Staph infection every year. According to Center for Disease Control and Prevention (CDC), there were 13 cases in 4 states of US, during 2002-2013. In due course of time, the species of Staphylococcus aureus have developed resistance to many of the antimicrobial drugs such as the MRSA, a class of staphylococcus aureus which is resistant to methicillin. Other than the majorly known Staph infection, it is also the common contributing agent for illnesses such as boils, impetigo, pimples, abscesses, and certain serious diseases such as pneumonia, meningitis, osteomyelitis, sepsis, and others. Thus, to treat such illnesses, the global staphylococcus aureus CA MRSA drug market is likely to grow further during the forecast period.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Drug Class
- By Route of Administration
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Pfizer Inc., Merck & Co., Inc., and AbbVie Inc., among others.
(Get 15% Discount on Buying this Report)
A full Report of Methicillin-Resistant Staphylococcus Aureus (MRSA) Drug Market is Available @ https://www.omrglobal.com/industry-reports/methicillin-resistant-staphylococcus-aureus-mrsa-drug-market
Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drug Market Report by Segment
By Drug Class
- Lipopeptides
- Oxazolidinones
- Cephalosporin
- Tetracycline
- Folate Antagonist
- Others
By Route of Administration
- Oral
- Parenteral
Global Methicillin-Resistant Staphylococcus Aureus (MRSA) Drug Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
